MDS (MYELODYSPLASTIC SYNDROME)
Clinical trials for MDS (MYELODYSPLASTIC SYNDROME) explained in plain language.
Never miss a new study
Get alerted when new MDS (MYELODYSPLASTIC SYNDROME) trials appear
Sign up with your email to follow new studies for MDS (MYELODYSPLASTIC SYNDROME), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New CAR-T therapy trial targets Tough-to-Treat blood cancers
Disease control Recruiting nowThis early-stage trial is testing the safety and effectiveness of an experimental treatment called ARD103 for adults with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) that has returned after treatment or hasn't responded to standard therapies. ARD103 is a type o…
Matched conditions: MDS (MYELODYSPLASTIC SYNDROME)
Phase: PHASE1, PHASE2 • Sponsor: ARCE Therapeutics, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New transplant method aims to cure blood diseases with fewer complications
Disease control Recruiting nowThis study is testing a modified stem cell transplant procedure for people with severe blood disorders like aplastic anemia. Researchers are adjusting how donor cells are collected and given to try to reduce serious side effects while still successfully replacing the patient's fa…
Matched conditions: MDS (MYELODYSPLASTIC SYNDROME)
Phase: PHASE2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
New shot aims to speed blood recovery after cancer transplant
Disease control Recruiting nowThis study is testing if a weekly injection called Romiplostim N01 can help platelets recover faster after a stem cell transplant for blood cancers like leukemia. About 130 patients will be randomly assigned to receive either the new drug or standard care, and researchers will tr…
Matched conditions: MDS (MYELODYSPLASTIC SYNDROME)
Phase: PHASE1 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Pioneering trial tests 'Off-the-Shelf' bone marrow from deceased donors
Disease control Recruiting nowThis early-stage study is testing the safety and feasibility of using bone marrow from deceased donors for patients with various blood cancers like leukemia and lymphoma. The goal is to see if this type of transplant can help patients when a living donor isn't available. Research…
Matched conditions: MDS (MYELODYSPLASTIC SYNDROME)
Phase: PHASE1, PHASE2 • Sponsor: Ossium Health, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Broccoli compound tested to speed up recovery in blood cancer patients
Disease control Recruiting nowThis study is testing whether a dietary supplement called sulforaphane, found in foods like broccoli, is safe and can help patients recover their blood cell counts faster after a cord blood transplant. It will involve 36 adults with serious blood cancers like leukemia who receive…
Matched conditions: MDS (MYELODYSPLASTIC SYNDROME)
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC
-
New drug combo aims to free MDS patients from frequent blood transfusions
Disease control Recruiting nowThis study is testing whether combining two drugs, luspatercept and darbepoetin alfa, can help patients with a specific, lower-risk form of myelodysplastic syndrome (MDS) who need regular blood transfusions. The main goal is to see if the treatment can help patients go longer per…
Matched conditions: MDS (MYELODYSPLASTIC SYNDROME)
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New hope for blood cancer patients: trial tests better protection after transplants
Disease control Recruiting nowThis study aims to find the best drug combination to prevent graft-versus-host disease (GVHD), a serious complication where donor immune cells attack the patient's body after a stem cell transplant. Researchers are comparing two new drug combinations against the current standard …
Matched conditions: MDS (MYELODYSPLASTIC SYNDROME)
Phase: PHASE2 • Sponsor: Center for International Blood and Marrow Transplant Research • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
New hope for patients Who've run out of options: early trial tests novel blood cancer drug
Disease control Recruiting nowThis is a first-in-human study to test a new drug called CG009301 in adults with blood cancers that have returned or stopped responding to standard treatments. The main goals are to find a safe dose and see how the body processes the drug. About 45 participants will receive the t…
Matched conditions: MDS (MYELODYSPLASTIC SYNDROME)
Phase: PHASE1 • Sponsor: Cullgen (Shanghai),Inc • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC